Ameriprise’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Sell |
|
|||||
|
2025
Q1 | $325K | Buy |
|
|||||
|
2024
Q4 | $292K | Sell |
|
|||||
|
2024
Q3 | $874K | Buy |
|
|||||
|
2024
Q2 | $795K | Sell |
|
|||||
|
2024
Q1 | $2.09M | Buy |
|
|||||
|
2023
Q4 | $941K | Sell |
|
|||||
|
2023
Q3 | $584K | Buy |
|
|||||
|
2023
Q2 | $1.18M | Buy |
|
|||||
|
2023
Q1 | $439K | Buy |
|
|||||
|
2022
Q4 | $190K | Sell |
|
|||||
|
2022
Q3 | $1.91M | Buy |
|
|||||
|
2022
Q2 | $1.98M | Buy |
|
|||||
|
2022
Q1 | $2.72M | Sell |
|
|||||
|
2021
Q4 | $29.9M | Sell |
|
|||||
|
2021
Q3 | $47.2M | Buy |
|
|||||
|
2021
Q2 | $58M | Buy |
|
|||||
|
2021
Q1 | $51.3M | Buy |
|
|||||
|
2020
Q4 | $24.1M | Sell |
|
|||||
|
2020
Q3 | $13.5M | Sell |
|
|||||
|
2020
Q2 | $12.1M | Sell |
|
|||||
|
2020
Q1 | $11.2M | Sell |
|
|||||
|
2019
Q4 | $38.2M | Buy |
|
|||||
|
2019
Q3 | $23.3M | Buy |
|
|||||
|
2019
Q2 | $14.3M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $862K | Buy |
|